Explore our core discovery modules, bio-assay validations, and analytical method establishments tailored for multinational regulatory dossiers.
Transitioning from empirical traditional pharmacology to verifiable molecular evidence through cutting-edge chromatography, multi-omic bio-assays, and regulatory data integrity.
“Natural medicine and functional therapeutics achieve cross-border commercial scalability solely when molecular identity, chromatographic purity, and pharmacodynamic profiles can withstand the intense scrutiny of multinational regulatory dossiers. By unifying botanical taxonomy with high-dimensional spectrometry, we bridge the gap between agrarian variance and pharmaceutical-grade repeatability.”
— MedGence Scientific Leadership & Analytical GovernanceHow domestic vertical integration delivers lower operational friction, robust origin traceability, and unrivaled cost-to-potency efficiencies.
Direct agro-scientific monitoring at certified Chinese Daodi production regions. We evaluate terroir, altitude, and harvesting chronologies to minimize secondary metabolite variability before industrial processing.
Seamless tech transfer from 5-liter laboratory discovery extractors to metric-ton automated continuous countercurrent extraction plants, avoiding the classic yield crashes seen in disjointed CRO setups.
Access to our proprietary database encompassing hundreds of thousands of pilot and industrial batches, permitting rapid predictive modeling of botanical behavior during purification and drying stages.
Entrusted contract manufacturing models governed by bilateral Non-Disclosure Agreements, isolated cleanrooms, and stringent firewall software, keeping unique formulations globally proprietary.
Ensuring analytical dossiers, heavy metal thresholds, pesticide residual screens, and novel food submissions harmonize with FDA, EMA, NMPA, and TGA requirements.
Implementation of high-performance thin-layer chromatography (HPTLC), HPLC-DAD, and GC-MS fingerprints that map distinct active markers alongside whole-spectrum characteristic profiles to defeat adulteration.
Exhaustive quantification of elemental impurities via ICP-MS, alongside multi-residue screening for over 500 pesticides and mycotoxins, fulfilling USP <561>, Ph. Eur. 2.8.13, and California Prop 65 safety parameters.
Formulation files, method validation packages (ICH Q2(R1)), and longitudinal accelerated stability datasets engineered specifically for regulatory filing packages and institutional board reviews.
Addressing the paradigm shifts in natural active compound synthesis, functional consumer demands, and sustainability mandates.
Global brands no longer accept unsubstantiated botanical mixtures. Procurement now mandates in vitro cellular efficacy mechanisms, animal pharmacokinetic profiles, and targeted randomized human trials.
Transition from petroleum-derived organic solvents to subcritical water extraction, supercritical CO2 fractionation, and enzymatic digestion to protect active compound conformations while eliminating VOC emissions.
Enterprise procurement professionals utilize dual-sourcing programs anchored by certified Chinese manufacturers to buffer geopolitical trade shifts and guarantee batch stability across rolling seasonal cycles.
Demand is surging for turnkey CDMO capabilities producing water-soluble granular suspensions, targeted enteric capsules, and micro-encapsulated oils that elevate consumer bio-availability.
Translating validated botanical actives into customized industrial formulations configured for bioavailability, shelf-life, and regulatory compliance.
Providing standardized extracts with quantified polyphenol, saponin, or polysaccharide contents. We provide full stability documentation, flowability optimization for high-speed tableting, and softgel encapsulation ready for retail distribution.
Partnering with biotechnology firms to support new drug applications (IND/NDA). Services span lead compound isolation, metabolic pathway analysis, GLP animal safety studies, and pilot production under strict current Good Manufacturing Practices (cGMP).
Isolating pure volatile terpenes, polyphenols, and bioactive flavonoids with proven skin permeation profiles. Formulations undergo rigorous in vitro cell line testing for anti-inflammatory, tyrosinase inhibition, and matrix metalloproteinase regulation to support clean beauty claims.
Our analytical and contract research workflows are embedded within the supply chains of industry leaders and university medical centers.
Direct technical answers addressing analytical methods, confidentiality, lead times, and regulatory support.
Select your required development stage or partner with our scientists for full bench-to-commercial deployment.
